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Abstract
With the need to understand the potential biological impact of the plethora of nanoparticles (NPs) 
being manufactured for a wide range of potential human applications, due to their inevitable human 
exposure, research activities in the field of NP toxicology has grown exponentially over the last decade. 
Whilst such increased research efforts have elucidated an increasingly significant knowledge base 
pertaining to the potential human health hazard posed by NPs, understanding regarding the possibility 
for NPs to elicit genotoxicity is limited. In vivo models are unable to adequately discriminate between 
the specific modes of action associated with the onset of genotoxicity. Additionally, in line with the 
recent European directives, there is an inherent need to move away from invasive animal testing 
strategies. Thus, in vitro systems are an important tool for expanding our mechanistic insight into NP 
genotoxicity. Yet uncertainty remains concerning their validity and specificity for this purpose due to the 
unique challenges presented when correlating NP behaviour in vitro and in vivo. This review therefore 
highlights the current state of the art in advanced in vitro systems and their specific advantages and 
disadvantages from a NP genotoxicity testing perspective. Key indicators will be given related to how 
these systems might be used or improved to enhance understanding of NP genotoxicity.
Introduction
Due to their unique physical and chemical characteristics, nano-
particles (NPs) exhibit distinctly different properties to their bulk 
counterparts, which can directly contribute to their alternative 
biological interaction and subsequent impact (1). Predominantly, 
physico-chemical characteristics of NPs, including geometry, solu-
bility, surface area, surface reactivity and surface chemistry, have 
been noted to drive this phenomenon (2). Further, it has been well-
documented in recent years that the NP interaction (i.e. biological 
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impact, entry mechanism and intracellular fate) is highly cell type 
dependent (3).
Concomitant with their production, the commercial applica-
tion of NPs is constantly increasing. For example, carbon nano-
tubes (CNTs) have been noted as having a production at the tonne 
level per year (4) e.g. car tyres, sporting equipment and electronics 
amongst other applications (5). Thus, understanding the potential 
adverse impact NPs may pose towards human and environment 
health is of heightened importance (6). Despite this, the necessary 
methodologies to enable this approach have been significantly lack-
ing over the years (7,8). Whilst initial efforts within the field were 
focused towards adapting conventional biochemical testing proto-
cols to overcome NP test system interference issues (9), in recent 
years, attention has been directed towards alternative testing systems 
(to in vivo strategies), most notably in vitro models. Adoption of 
this perspective was further emphasised through recent legislative 
change, i.e. the EU cosmetics directive [Directive 86/609/EEC (10) 
and Directive 2010/63/EU (11)].
Historically, an acute exposure scenario to NPs has been the 
basis for the plethora of research articles published (12). However, 
in order to interpret their potential hazard, study of the inevitable 
human exposure to nanosized materials must be considered accu-
rately. Therefore, emphasis should be directed towards the more 
realistic repeated, chronic and low-dose exposure to the many dif-
ferent NPs and NP-orientated applications produced (13). With this 
exposure scenario in mind, the potential for NPs to cause genotox-
icity has, most recently, received increased interest and risen to the 
forefront of nanotoxicology research (7).
Genetic damage can arise either through primary (direct or indi-
rect) or through secondary mechanisms (14). Primary direct DNA 
damage requires the NPs to locate within the nucleus of a cell, inter-
acting with and leading to physical DNA damage (15). This could 
result in the formation of DNA lesions and potential mutagenesis 
due to error-prone repair, physical strand breakages or frameshift 
mutations (due to the NP size, they could act as an intercalating 
agent with DNA base pairs) (16). Nonetheless, despite only a few 
studies showing that NPs can enter the nucleus (17), there is limited 
evidence supporting the potential for NPs to cause primary direct 
genotoxicity. Lovrić et al. showed quantum dots (diameter 2–3 nm) 
to be present in the nucleus of MCF-7 human breast cancer cells, 
yet reported no genotoxicity to occur despite a noted increase in 
cellular oxidative stress levels after a 15-h exposure at 10 μg/mL. 
Oxidative stress is considered a key mechanism in primary indi-
rect genotoxicity, occurring from excessive reactive oxygen species 
(ROS) production which in turn creates an imbalance in the cellular 
ROS:antioxidant (18,19). To date, research related to deciphering 
NP genotoxicity has demonstrated (20) or eluded (21) to the notion 
that NP-associated DNA damage occurs through primary indirect 
means. In this scenario, the NP is not physically interacting with 
the DNA, but instead promoting damage through other molecules 
that either have the capacity to interact with DNA to induce lesions 
or interfere with DNA replication and cell division (e.g. cell cycle-
associated proteins, damage to DNA replication or repair enzymes 
and/or oxidative stress). Various mechanisms exist by which this 
could occur, such as a by-product of an induced (pro-)inflammatory 
response, interaction with cellular components or the high surface 
reactivity and/or solubility of the NP itself (22,23).
Importantly, both primary mechanisms for DNA damage are 
solely limited to considering the genotoxic influence of NPs that are 
associated [i.e. internalised and/or membrane bound (including the 
extracellular fraction)] with a single cell (type). In this regard, with the 
NP genotoxicity literature dominated by in vitro/ex vivo monoculture 
analyses, primary indirect particle genotoxicity can arguably be con-
sidered the dominant research focus within nanogenotoxicology to 
date [including the Trojan horse effect (24)]. Yet the main genotoxic 
mechanism noted in vivo is secondary genotoxicity, due to the cell-to-
cell interplay that occurs in vivo during any foreign body stimulus. It 
must be stressed therefore, that as most in vitro studies in nanogeno-
toxiciology have not considered this aspect, the true mechanism of 
NP-associated genotoxicity is not, currently, fully understood.
Secondary genotoxicity is denoted in vivo as a result of mecha-
nistic, chronic inflammation caused by activation/recruitment of 
immune cells, such as macrophages and/or neutrophils (25). These 
phagocytic cells function in vivo as an initial immune defence 
mechanism against invading microorganisms and aid in the clear-
ance of foreign materials (such as from the lung tissue). Using the 
lung as an example, as it is the primary route of human exposure 
to NPs, if clearance of inhaled particulate is unsuccessful it can cre-
ate a chronic immune cell response. Classically, this would involve 
a respiratory burst, flooding the tissue with ROS and reactive nitro-
gen species. This process can result in a vicious circle of free radi-
cal production and immune cell recruitment. Indeed, ROS produced 
via nicotinamide adenine dinucleotide phosphate oxidase activation 
has been identified as a vital neutrophil recruitment factor in lung 
tissue (26). Thus, with consideration that NP-associated genotoxic-
ity could also arise through secondary genotoxicity mechanisms, it 
is vital that such a mechanistic understanding is gained. Not only 
would this further elucidate the potential hazard posed by NPs to 
human health, it would provide important information to support 
the safe-by-design approach of NPs (27,28). Currently however, 
there are deficiencies in using standard monoculture systems to 
assess the ability for NPs to instigate secondary genotoxicity. The 
aim of this critical review, therefore, is to consider the range of cur-
rently available advanced in vitro systems and their potential to be 
used to study secondary genotoxicity mechanisms. Focus will be 
given to the advantages and disadvantages posed by these systems 
towards deducing NP-associated genotoxicity as well as an outlook 
on what is needed moving forward to enable such in vitro systems to 
replace in vivo testing strategies.
In vitro systems for nano(geno)toxicology research
A recent review by Hartung and Sabbioni highlighted an array of 
alternative systems that are available for toxicology research (29). 
A  further review highlighted the need for an in vitro approach 
towards nanotoxicology research strategies (predominantly in light 
of the recent EU directive (Directive 2010/63/EU) (30). Yet there 
remains a clear void of understanding as to how advanced in vitro 
systems might or could be used for nanogenotoxicology testing. 
Whilst 2D monocultures have predominantly been used in the field, 
they exhibit significant flaws that render them irrelevant to be used 
in testing for NP-associated (secondary) genotoxicity. Nonetheless, 
as described throughout this critical review, there are numerous 
advanced, potentially alternative in vitro models available that could 
be more suitable in this specific aspect of the NP toxicology field.
2D Monocultures
To date, the majority of in vitro studies assessing the potential for 
NPs to exert a genotoxic response have been performed using 2D 
monoculture systems. Any 2D in vitro system suitable for genotoxic-
ity testing should highly consider cell types recommended by OECD 
guidelines and which have appropriate genetic stability, low DNA 
damage background and functional p53 activity (31). In a number 
In vitro systems for nanogenotoxicology, 2017, Vol. 32, No. 1 235
of nanogenotoxicology studies however, a contentious issue revolves 
around the choice of cell type used, because a number of investi-
gations use cell lines that are irrelevant towards the prediction of 
genetic damage in a target organ (32). Typically, a cell choice will 
be representative of a region of the body the NP is liable to interact 
with. For instance, the epithelial layer of the alveolar barrier in the 
human lung can be (loosely) represented by the A549 cell line or the 
bronchial region of the human respiratory tract by the bronchial cell 
lines BEAS-2B or 16HBE14o− (33–39).
Single-cell in vitro-based testing techniques, especially those 
utilising immortalised cell lines, offer the advantages of being 
relatively low cost, high throughput and reproducible. They are 
also highly useful when conducting initial cytotoxic screenings 
and when choosing suitable dose ranges (for in vivo studies) (40). 
However, 2D in vitro systems are highly limited with regard to 
their representation of the in vivo tissue. Typically, in vivo organ/
tissue/cell structures are not the flat planer structures represented 
by most monocultures, instead they are complex geometrical (e.g. 
3D) structures consisting of multiple cell types. Monocultures lack 
this complexity and structural coordination as well as the specific 
physiological components, thereby limit inter-, intra- and extracel-
lular communications that influence function, proliferation, differ-
entiation, gene expression profiles and cell death. Therefore, taking 
these limitations into consideration, current standard in vitro geno-
toxicity tests are associated with a lack of sensitivity and specific-
ity in terms of the cell cultures used. Although 2D monoculture 
models are largely well-suited to evaluating primary genotoxicity, 
it is important to note that they are unable to detect mechanisms 
of secondary genotoxicity. Thus, these disadvantages of 2D in vitro 
assays has resulted in an heightened interest in alternative models 
to assess NP (secondary) genotoxicology. To date, a number of dif-
ferent, advanced in vitro models, as described in Table 1, have been 
developed varying in their degree of complexity and highlighting 
the progression of in vitro systems potentially available for nanog-
enotoxicity testing strategies.
The purpose of these advanced models is to create representa-
tion of specific organs of the body (e.g. lung, liver, heart and brain), 
beyond that of monoculture systems (29). Such complex in vitro 
models are being increasingly applied in the field of nanotoxicology, 
but to date, their use has been limited in assessing the genotoxic 
potential of NPs, and they likely require some adaptation to support 
the evaluation of DNA damage endpoints (41).
The conditioned culture medium approach
Typically, this approach has been applied to investigate the impact 
of an initial immune response upon other cell types [e.g. barrier cells 
(epithelial cells)], as it would occur in vivo. Although attempting to 
mimic this scenario, and ongoing biochemical effects, the transfer of 
conditioned culture medium from one cell type to another follow-
ing NP treatment is elementary. Arguably the most straightforward 
means of exploring the impact of extracellular signalling of all avail-
able advanced in vitro systems, this technique, although considering 
cellular biochemical interplay, does not reflect the important cell-to-
cell interplay that occurs in vivo.
An example of this in vitro approach is shown by Barlow et al., 
in which type II alveolar epithelial cells were initially treated with 
carbon black NPs. It was noted that a significant pro-inflammatory 
response occurred in the epithelial cells, yet when this conditioned 
cell culture media (containing the pro-inflammatory mediators) 
was subsequently applied to alveolar macrophages, it proceeded to 
engage macrophage chemotaxis (42). Further, in the study of Shaw 
et al., cell culture media was retained from macrophages exposed to 
diesel exhaust particles (DEPs) and then applied to human umbili-
cal vein endothelial cells (HUVECs). It was observed that the sub-
sequent exposure of the conditioned media promoted a dramatic 
amplification of monocyte chemotactic protein (MCP-P) and inter-
leukin (IL)-6 in the HUVEC cells (43). An additional example, more 
recently, showed that conditioned media obtained by treatment of 
THP-1 macrophages with long CNTs elicited an increased produc-
tion of IL-1β in Met5a mesothelial cells, which provided important 
information upon the hazard potential of CNTs with similar phys-
ico-chemical characteristics to amosite asbestos fibres (44).
In terms of genotoxicity, the application of conditioned media 
from one cell type onto the target cells would facilitate a basic, albeit 
non-specific understanding of the importance of secondary mecha-
nisms for DNA damage. Although, as mentioned above, it would 
not consider the importance of cellular interplay, and there would be 
uncertainty associated with the potency of the extracellular media-
tors exposed to the second cell type, this methodology does eliminate 
the (many) practical problems associated with using co-cultures to 
assess secondary genotoxicity, such as the isolation of the different 
cell types required to ensure analysis is restricted to the target cells 
in the model. Furthermore, it would enable straightforward use of 
the already established genotoxic tests, such as the COMET and 
Table 1. Summary of the advanced in vitro systems currently available and used within the field of nano(geno)toxicology
Advanced in vitro system Description Advantages/disadvantages
Conditioned media treatments Transfer of conditioned culture media  
from one cell culture (exposed to e.g. NPs)  
to another cell culture (i.e. commonly a  
different cell type).
Straightforward, cost-effective methodology. 
Considered a crude technique that does not allow cellular interplay.
Potential toxicity mediators lost during media transfer.
Co-cultures Multiple (i.e. two or more) cell types cultured 
together in the same well which represents a 
specific organ/tissue type.
Allows for important cellular interplay, and if cultured correctly 
can represent important cell types (in possible anatomical manner) 
relevant to (NP) target organ.
Relative high cost and laborious nature (requiring expert culture).
Microtissues (e.g. spheroids, 
organoids)
Cells cultured in a manner that allows  
them to formulate into an (anatomically  
correct) geometric structure (e.g. 3D  
tissue-like structure).
Highly representative of the organ/tissue being studied. Highlights 
important cellular interplay and anatomical structure.
High cost, laborious, short-shelf life and difficult to use for certain 
biochemical endpoints.
Complex 3D structures Models that are typically  
pre-made/purchased and representative of  
specific organs/tissues.
Closely mimics in vivo
High cost, laborious, expertise required and not possible to achieve 
all biochemical endpoints.
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micronucleus tests, and not require further methodological changes 
to deduce the potential genotoxicity of any NP type.
Co-culture systems
The next level of complexity in ‘advanced in vitro systems’ involves 
co-culture models, comprised of either two or more different cell 
types. Although these systems do not necessarily always form a 3D 
architecture, they encompass cell-to-cell interplay, which promotes 
intracellular signalling and molecular cross-talk that closely mimic 
the in vivo environment following inhalation of NPs (such as within 
an occupational exposure environment). A prime example of such 
a model is the alveolar airway barrier model developed by Rothen-
Rutishauser et  al. (45). This triple cell co-culture model consists 
of alveolar lung epithelial cells (commonly A549 cells), as well as 
human blood monocyte-derived macrophages and dendritic cells 
constructed in an anatomically associated manner. Since its estab-
lishment, the model has been applied to a wide range of studies that 
have primarily focused on cellular entry mechanisms of NPs and 
their subsequent cytotoxic, oxidative stress and pro-inflammatory 
responses. As with any multicellular system, question marks remain 
as to their superiority beyond monocultures. Recently, this question 
was investigated with the co-culture model of Rothen-Rutishauser 
et al. (45). It was demonstrated following CNT exposure that the co-
culture model showed a greater pro-inflammatory cytokine (meas-
ured by tumour necrosis factor-α) and chemokine (measured by 
IL-8) response compared with the same CNT treatments on mono-
cultures of each independent cell type of the co-culture model (46).
Due to its high relevance in the field, in terms of NP inhala-
tion being the primary route of exposure to the human body, the 
application of a lung co-culture model has been a recurring theme 
within the nanotoxicology field. Several research groups have also 
constructed similar models since 2005, with structural variation (47) 
as well as differences in the cell types used (48). Similar toxicologi-
cal questions have been asked of these co-cultures as to the one of 
Rothen-Rutishauser et al. (45), yet limited genotoxicity assessment 
of any NP type has been conducted using these models. In addition, 
various other co-culture models have been constructed to represent 
other organs of the body; e.g. the gut has been a key area of inves-
tigation due to the potential ingestion of NPs [e.g. titanium dioxide 
(TiO2) NPs through their application as food additives]. Thus, a co-
culture of colon epithelial cells (CaCo-2), THP-1 macrophages and 
MUTZ-3 dendritic cells have been constructed to assess NP toxicity 
in healthy and diseased conditions (49). Moreover, a model consist-
ing of CaCo-2 cells and another colon epithelial cell line (HT29-
MTX) has also been applied to assess the ability of the gut mucosa to 
change the physico-chemical characteristics of polystyrene NPs (50).
In all cases, the application of co-culture models to nanotoxicol-
ogy has primarily been focused on uptake, pro-inflammatory and 
cytotoxicity studies with a very limited number investigating DNA 
damage. Yet comparisons have been made between the ability of DEPs 
(as a bulk sample, not just the NP fraction) to induce DNA damage in 
both mono- and co-cultured lung epithelial cells and macrophages. It 
was shown that in a macrophage/lung epithelial co-culture, there was 
a loss in the ability for DEPs to cause DNA damage when compar-
ing this endpoint (determined by the COMET assay) in mono- and 
co-culture systems due to the pivotal, ‘protective’ effect that (alveo-
lar) macrophages play on the apical layer of the epithelial layer (51). 
Moreover, correlation of a model consisting of lung epithelial and 
endothelial cells with in vivo gene expression data following multi-
walled CNTs (MWCNTs) exposure indicated, to a small degree, the 
potential comparability of in vitro and in vivo models (52). Yet, in this 
study, the immune response measured was dampened due to the lack 
of any phagocytic cells present in the in vitro system. Nonetheless, 
the findings of Snyder-Talkington et al. are of significant importance 
in the perspective of alterative in vivo model systems. It is also worth 
highlighting that in their approach, Snyder-Talkington et al. used a 
variety of genes associated with genotoxicity to determine the impact 
of MWCNTs. Whilst this is not direct genotoxic assessment, it again 
shows a clear path of how to approach a difficult methodological 
issue. Whilst it can be considered that the use of co-culture models 
for genotoxicity assessment would provide significant and useful 
data on the potential for NPs to cause secondary genotoxicity, they 
however present with a number of practical issues. The most promi-
nent limitation is the difficulty in isolating each cell type of interest 
for DNA damage evaluation. An example of this was presented by 
Jantzen et al. who stated that the nucleoids for both epithelial cells and 
macrophages looked identical under the fluorescence microscopy (51). 
Thus, the authors were unable to discriminate as to which cell type the 
scored nucleoids originated from. This issue has also been associated 
with other genotoxicity testing strategies, such as the γ-H2ax assay. 
Similarly, via gene-based approaches, the ability to deduce the precise 
cell type without any initial or real-time identification of the different 
cell types in the multicellular system is a significant disadvantage in 
using these advanced models. In an attempt to overcome this issue 
however, Clift et al. who have devised a straightforward cell pheno-
typic flow cytometry-based approach to determine each specific cell 
type of a co-culture system following their isolation (M. J. D. Clift et 
al., unpublished). Yet, irrespective of this approach, due to the specific 
methodological protocols associated with some individual genotoxic-
ity tests, it will not always be possible to identify the different cell 
types (e.g. the COMET assay, where all cells are lysed prior to analy-
sis). For assays that involve microscopy-based techniques, cell identi-
fication is potentially less problematic and could therefore be applied 
to tests such as the cytokinesis block micronucleus (CBMN) assay, as 
well as the flow cytometric version of this assay (53), where cells with-
out the correct fluorescent label could easily be excluded from scoring. 
Irrespective of this potential solution, there remains a significant issue 
with most, if not all, currently validated in vitro mammalian genotox-
icity tests where two or more cell types are cultured together.
Microtissues (spheriods/organoids)
Moving further into in vitro complexity, microtissues show an 
additional level of in vivo association to multicellular systems. 
A major disadvantage of co-culture models is that they lack a spe-
cific 3D architecture, a significant characteristic of in vivo tissue. 
Alternatively, 3D cellular microtissues, where cells are cultured in 
a manner that supports their growth in a 3D tissue-like structure, 
replicate in vivo tissue behaviour (54). It must be noted though that 
microtissues can be also be referred to as spheroids and/or orga-
noids. Various approaches have been developed in forming these 3D 
cell aggregates and include the use of bioreactors and microfluidic 
devices, as well as formation of hanging drop cultures, together with 
layered and matrix scaffolds (54,55).
Due to its versatility to integrate with other assays, ease of use 
and scalability, as well as the ability to produce homogenous sized 
spheroid systems, the hanging drop method is of common interest 
throughout the in vitro community. This technique can be applied to 
a number of different cell types and is considered an ideal 3D model 
for nanotoxicology strategies as their structure provides a biologi-
cal barrier in addition to augmented in vivo-like cell functionality. 
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Thus, these in vitro systems can be used to mimic any of the body’s 
organ type structure and therefore represent exposure via any of the key 
routes to the human body (e.g. inhalation, injection, ingestion and skin 
exposure) of NPs and NP-associated applications. Indeed, comparison 
between monocultures and spheroids treated with both gold NPs and 
quantum dots demonstrated that lower toxicity occurred in spheroids 
compared with the 2D monocultures (56). Reason for this is that the 
layered cell 3D structure offered by these models mean that particle size 
and agglomeration becomes an even greater consideration as it greatly 
impacts on penetration and localisation (Huang et al., 2012).
One key organ of interest, other than that of the lung, in nanotoxi-
cology is the liver, as toxicokinetics studies to date have demonstrated 
that it is often the primary site of accumulation following access of NPs 
that gain access into the systemic circulation (57,58). In vivo liver dam-
age associated with nanomaterial toxicity has already been reported 
(59–61). Commercial Insphero™ liver microtissues have been utilised 
in the genotoxic assessment of a panel of NPs including zinc oxide 
(ZnO), MWCNTs and TiO2 NPs. Each NP type induced DNA damage 
at varying treatment doses as measured by the COMET assay, with 
subsequent repeated exposure increasing DNA damage levels (62).
Genotoxicity studies with spheroids to date have only evalu-
ated DNA damage induced by NPs with the COMET assay. Thus, 
the COMET assay is typically overly sensitive and is also not able 
to detect aneugenicity; the regulatory in vitro testing battery there-
fore does not include the COMET assay and is restricted to mutation 
tests that quantify different forms of fixed genetic damage including 
the chromosome aberration assay, micronucleus assay or point muta-
tion analysis. However, application of these latter test systems to any 
microtissue model is not without its difficulties that require significant 
attention in order to deduce the full advantages posed by these sys-
tems for genotoxicity testing strategies. Nonetheless, there are exciting 
developments in the field with ongoing research to optimise the appli-
cation of the micronucleus assay with HepG2 liver spheroids, allow-
ing the extension of this test to take advantage of the benefits offered 
by improved tissue structure in microtissues (Figure 1) and to apply it 
towards exploring NP-associated (secondary) genotoxicity (63).
3D Reconstructed tissue models
Finally, beyond the previously discussed advanced in vitro mod-
els that can be adapted to meet the needs of the different human 
exposure routes to NPs (and their applications), a specific form of 
in vitro system can be used as regards NP skin exposures. These 
systems, known as 3D reconstructed skin models, have received 
increased attention in the genotoxicity field but as yet only limited 
investigation for NP-associated genotoxicity. A task force was initi-
ated by the European commission led by the European Centre for 
the Validation of Alternative Methods (ECVAM) to develop in vitro 
skin model-based assays (64). These systems consider the important 
cellular interplay that co-culture models present, however with the 
specific geometry and relevance that microtissues exhibit. However, 
further to these combined advantages of other in vitro model sys-
tems, 3D tissue structures further exhibit in vivo characteristics, e.g. 
connective tissue, which extends further the in vivo relevance of 
these in vitro systems.
This spawned a variety of 3D-reconstructed skin culture models 
such as the EpiDerm™, SenCeeTox™, KeraSkin™ and Straticell that 
represent a first point of contact following exposure of a cosmetic 
product and for skin sensitisation assays. These models are designed 
to represent a considered ‘normal’ epidermis with discernible basal, 
spinous and granular layers covered with a developed stratum cor-
neum. Additionally, they are comprised of human keratinocytes, 
removing the requirement for the rat liver S9 preparation as some 
models, such as the EpiDerm™ have xenobiotic metabolism relevant 
to human skin (65). The EpiDerm™ tissue has been applied to a 
limited number of nanotoxicology studies including the assessment 
of skin irritation by cerium oxide and silicon dioxide NPs (66,67). 
KeraSkin™ has also been compared with an in vivo model follow-
ing treatment with ZnO NPs where skin erosion and irritation were 
assessed by changes in cell viability. This study demonstrated that 
the in vitro data were comparable to the in vivo response with the 
reconstructed skin model (68).
The application of models such as these for the assessment 
of NP genetic damage is in contrast limited. Despite this, there 
has been an extensive international effort to adapt the CBMN 
assay for the use with the EpiDerm™ model, now known as the 
3D reconstructed skin micronucleus assay (RSMN). The RSMN 
assay has been undergoing pre-validation for the last 8 years with 
a standardised protocol in place and very good reproducibility 
(69–71). Efforts are now being placed on increasing throughput 
of the RSMN assay by the use of automated techniques such as 
the Metasystems Slide Scanning Platform (Metafer) (72). Although 
Figure  1. Scheme outlining the procedure associated with determining the micronucleus frequencies in spheroid cultures (HepG2 hanging drop cultures) 
exposed to dextran-coated Fe2O3 and Fe3O4 NPs.
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the RSMN assay is well accepted and offers a model of true bar-
rier representation, which has been applied to evaluate chemicals, 
its application in nano(geno)toxicology remains limited. To pro-
gress this, recent research has focused on comparing NP exposure, 
uptake and genotoxic response between 2D monocultures and 
the EpiDerm™ model. This research utilised cryogenic scanning 
electron microscopy to characterise NP dermal deposition and cell 
uptake assessment by transmission electron microscopy comparing 
the 2D and 3D models (Figure 2). The data gathered demonstrated 
the importance of 3D model architecture as the EpiDerm™ stratum 
coreum was an effective barrier to subcutaneous penetration and 
consequently preventing genotoxicity in the dividing basal cells of 
the model. In comparison, 2D results demonstrated NP uptake and 
dose-dependant genotoxicity (Figure 2) (73).
Summary and outlook
With growing pressure to move away from animal-based testing, 
there are constant advances within the field of in vitro culture tech-
nologies and models. Novel approaches involving manipulations of 
the current state of the art are developing at a fast pace, resulting in 
a range of in vitro models and systems that represent a wide variety 
of human organs and tissues, each of which are progressing signifi-
cantly towards mimicking the complete in vivo scenario and subse-
quent response. It is important to note however that there remains 
a void in understanding how truly alike the currently available in 
vitro systems are to the in vivo scenario. Whilst some of the literature 
eluded to in the present manuscript (52, 69) suggests that currently 
used in vitro systems exhibit similarities to in vivo, it is abundantly 
clear within the field that more efforts must be given towards actu-
ally comparing and confirming the proximity of such models to in 
vivo. Whilst this would begin to achieve the visions of the 3Rs in 
nano(geno)toxicology research (30), emphasis must also be towards 
enabling in vitro systems to mimic the human body and not just a 
replacement for animal experimentation.
In the current environment however, the options of advanced 
in vitro models represent a reasonable choice for specific organ/
tissue analysis, as well as a range of biochemical testing strategies. 
However, unfortunately it is not a simple case of selecting such a 
model and applying them towards standardised hazard assessment 
Figure 2. Comparison of 16 nm silica nanoparticle (NP) exposures in traditional 2D monocultures versus the 3D reconstructed skin model: 16 nm silica NP 
exposure to 2D monoculture cells resulted in cell membrane binding, uptake and consequentially concentration-dependent (geno)toxicity (A). Cryogenic 
scanning electron microscopy permitted the deposition state and surface coverage of the NPs (coloured red) to be assessed after topical inoculation onto the 
stratum corneum barrier layer of the 3D tissue model (B). Re-imaging after 72 h exposure in transverse section showed that the stratum corneum layer was 
an effective barrier to the silica NPs (red), as they only penetrated the very outermost layers of the stratum corneum layer (C; relative position of the electron 
micrograph in context of the complete model cross section shown by haematoxylin and eosin micrograph inset left). Consequently, no (geno)toxicity was found 
regardless of concentration, as the 3D microarchitecture of the model prevented silica NP exposure to the living cells of the tissue.
In vitro systems for nanogenotoxicology, 2017, Vol. 32, No. 1 239
testing strategies. Consequently, for genotoxicity testing, there 
remain a number of limitations and issues yet to be solved to truly 
deliver an in vitro system that is adequate for use. Furthermore, the 
complications of working with NPs raise additional technical hur-
dles that need to be overcome to allow the inclusion of advanced 
in vitro models in nanogenotoxicology testing. Nonetheless, these 
alternative models offer significant promise and advantage over the 
current, gold standard 2D monoculture systems including:
1. The ability to employ more realistic repeated or chronic expo-
sures due to the enhanced long-term stability of the more com-
plex multicellular architecture.
2. Multicellular models provide greater representation of in vivo 
organs and tissues, thereby more closely mimicking the cell-to-cell 
interplay that could influence behaviour following exposure to 
exogenous agents.
3. Availability of multiple tissue/organ systems to study intertissue/
organ translocation, accumulation and (geno)toxicity profiles.
4. The ability to evaluate a wider spectrum of modes of action, par-
ticularly the potential induction of secondary genotoxicity.
Despite the current flaws and limitations, the research area of 
advanced in vitro systems is an exciting field offering substantial 
advantages to aid the reduction of animal testing and promote the 
3Rs principles in the genotoxicity testing of NPs.
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